Greetings from MyCancerHaven!

We wanted to update you on our recent activities.

Here are the latest posts last week:

‍Blogs :

An Overview of CAR T-cell Therapy Options in Relapsed/Refractory Multiple Myeloma (R/R MM)

Dr. McCarthy on Neutrophil Activity in Multiple Myeloma

Dr. Sonneveld on the Background of the D-VRd Regimen for Newly Diagnosed Myeloma

MCH Minute Unavailable

Efficacy and Treatment-Free Interval Support Earlier Use of CAR T Therapy in RR MM

Dr. Banerjee on Different Dosing Schedules of Bispecific Antibodies in Myeloma

Dr. Krishnan on Maintenance Approaches in Transplant-Ineligible Multiple Myeloma

Expert Insights on Selinexor's Role and Key Takeaways in Multiple Myeloma

Aggressive Supportive Care After Novel Agents May Reduce Infection

‍Also at MCH the News and Tweets never stop flowing!

Join Us at www.mycancerhaven.org

‍The Team @ MCH

Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok

Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.